Mumbai, 28th June 2019: Eurolife Healthcare – Manufacturing and Distribution Company of Specialty Infusion & pharmaceuticals, today launched the high quality Intravenous IV products name Discport and Lifeport in the Indian drug market. Positioned as Smart Intravenous Infusion, both products encompass the best of the latest technology that reduce the chances of any infections apart from ease of use.
Discport- Does not require any venting which ensures safety. It can be sterilized at 121* C & has lowest endotoxin levels. There is nil chance of any microbiological contamination and No DEHP Exposure.
Lifeport, known as Closed System Infusion (C I V Infusion), is a premium product with two ports one for the infusion delivery and another one for the extra medication. Lifeport does not require venting. It is self-collapsible bottle ensuring Zero wastage of expensive medication. No DEHP exposure, no drug incompatibility and no medication error.
These products are the replacement to the presently used PE bottles (FFS bottles) the new PP bottles have better quality with additional features and are available at affordable prices to the patients.
Mr. Sandeep Toshniwal, CEO of Eurolife Healthcare said, “We are dedicated to save lives of patients with our reliable and quality conscious manufacturing of premium healthcare products. We have more than 24 years of uninterrupted manufacturing expertise with state of art manufacturing facilities.”
Eurolife Healthcare aims to serve high quality innovation products to save lives.
About Eurolife Healthcare Pvt Ltd:
Eurolife Healthcare Pvt. Ltd. – Mumbai, based specialty Pharmaceutical Company started in the year 2001, manufactures and distributes an exclusive portfolio of healthcare formulations, Intravenous Infusions, Ophthalmics, Sterilized water for Injections, Nebules, Tablets, Capsules, Ointment and Creams.
In the year 2018, the brand acquired No.1 position in India for I.V fluids.
Eurolife has the largest production capacity of Intravenous Infusions in India. After acquiring Baxter International FFS Division, Eurolife has made its hold even more strong in the domestic and worldwide markets. Aims to provide benchmark quality – Large Volume Parenterals / Small Volume Parenterals for the consumers at most economical prices. The driving force was the need of leading pharmaceutical organisation manufacturing assured quality products in this field.
To cater their domestic & global clients Eurolife have Strategic manufacturing plants disseminated in different geographies with Roorkee in North, Waluj in West and Alathur in South. Every year approx. 12,000 hospitals and nursing homes are touch based by the team of Eurolife Healthcare.
Company :-Orion PR & Digital Pvt. Ltd.
User :- Arshad Jamal